Harold E. Carlson, MD

Shirley A. Bembo, MD
Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Harold E. Carlson, MD
Professor, Department of Medicine, and Head, Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Address: Shirley A. Bembo, MD, Division of Endocrinology and Metabolism, Health Sciences Center, T15 Room 060, Stony Brook University, Stony Brook, NY 11794-8154

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Shirley A. Bembo, MD
Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Harold E. Carlson, MD
Professor, Department of Medicine, and Head, Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Address: Shirley A. Bembo, MD, Division of Endocrinology and Metabolism, Health Sciences Center, T15 Room 060, Stony Brook University, Stony Brook, NY 11794-8154

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Shirley A. Bembo, MD
Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Harold E. Carlson, MD
Professor, Department of Medicine, and Head, Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook

Address: Shirley A. Bembo, MD, Division of Endocrinology and Metabolism, Health Sciences Center, T15 Room 060, Stony Brook University, Stony Brook, NY 11794-8154

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.